These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 35039879)

  • 1. [Retracted] miR‑218 suppresses tumor growth and enhances the chemosensitivity of esophageal squamous cell carcinoma to cisplatin.
    Tian H; Hou L; Xiong YM; Huang JX; She YJ; Bi XB; Song XR
    Oncol Rep; 2022 Mar; 47(3):. PubMed ID: 35039879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Retracted] Silencing XIAP suppresses osteosarcoma cell growth, and enhances the sensitivity of osteosarcoma cells to doxorubicin and cisplatin.
    Qu Y; Xia P; Zhang S; Pan S; Zhao J
    Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34726252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Retracted] miR‑365 targets ADAM10 and suppresses the cell growth and metastasis of hepatocellular carcinoma.
    Liu Y; Zhang W; Liu S; Liu K; Ji B; Wang Y
    Oncol Rep; 2022 Nov; 48(5):. PubMed ID: 36102315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Retracted] MicroRNA‑154 functions as a tumor suppressor in osteosarcoma by targeting Wnt5a.
    Zhou H; Zhang M; Yuan H; Zheng W; Meng C; Zhao D
    Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34278509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Retracted] Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma
    Liu J; Dong BF; Wang PS; Ren PY; Xue S; Zhang XN; Han Z; Chen G
    Oncol Rep; 2022 May; 47(5):. PubMed ID: 35234269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Retracted] Synergistic growth inhibition by sorafenib and cisplatin in human osteosarcoma cells.
    Yang Q; Zhang S; Kang M; Dong R; Zhao J
    Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34278510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Retracted] miR‑133a inhibits cervical cancer growth by targeting EGFR.
    Song X; Shi B; Huang K; Zhang W
    Oncol Rep; 2021 Jul; 46(2):. PubMed ID: 34080664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Retracted] miR‑338‑3p suppresses tumor growth of ovarian epithelial carcinoma by targeting Runx2.
    Wen C; Liu X; Ma H; Zhang W; Li H
    Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retracted] Synthetic miR‑145 mimic inhibits multiple myeloma cell growth
    Zhang Q; Yan W; Bai Y; Xu H; Fu C; Zheng W; Zhu Y; Ma J
    Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34184081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Retracted] miR-126 inhibits papillary thyroid carcinoma growth by targeting LRP6.
    Wen Q; Zhao J; Bai L; Wang T; Zhang H; Ma Q
    Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34080656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Retracted] miR‑154 targeting ZEB2 in hepatocellular carcinoma functions as a potential tumor suppressor.
    Pang X; Huang K; Zhang Q; Zhang Y; Niu J
    Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34132377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Retracted] miR‑138 inhibits gastric cancer growth by suppressing SOX4.
    Pang L; Li B; Zheng B; Niu L; Ge L
    Oncol Rep; 2022 Mar; 47(3):. PubMed ID: 35014683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Retracted] miR‑222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma.
    Liu K; Liu S; Zhang W; Ji B; Wang Y; Liu Y
    Int J Oncol; 2021 Dec; 59(6):. PubMed ID: 34726253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Retracted] Knockdown of CREB1 inhibits tumor growth of human gastric cancer
    Rao M; Zhu Y; Cong X; Li Q
    Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34617576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Retracted] miR‑137 acts as a tumor suppressor in papillary thyroid carcinoma by targeting CXCL12.
    Dong S; Jin M; Li Y; Ren P; Liu J
    Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34318908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Retracted] miR‑494 promotes cell proliferation, migration and invasion, and increased sorafenib resistance in hepatocellular carcinoma by targeting PTEN.
    Liu K; Liu S; Zhang W; Jia B; Tan L; Jin Z; Liu Y
    Oncol Rep; 2022 Feb; 47(2):. PubMed ID: 34850964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Retracted] MicroRNA‑128 suppresses cell growth and metastasis in colorectal carcinoma by targeting IRS1.
    Wu L; Shi B; Huang K; Fan G
    Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34278481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Retracted] PAX6, a novel target of miR-335, inhibits cell proliferation and invasion in glioma cells.
    Cheng Q; Cao H; Chen Z; Ma Z; Wan X; Peng R; Jiang B
    Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Retracted] MicroRNA‑874 inhibits growth, induces apoptosis and reverses chemoresistance in colorectal cancer by targeting X‑linked inhibitor of apoptosis protein.
    Han J; Liu Z; Wang N; Pan W
    Oncol Rep; 2022 Apr; 47(4):. PubMed ID: 35137925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Retracted] miR‑124 inhibits proliferation and invasion of human retinoblastoma cells by targeting STAT3.
    Liu S; Hu C; Wang Y; Shi G; Li Y; Wu H
    Oncol Rep; 2021 Nov; 46(5):. PubMed ID: 34558651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.